Use Case I

Transforming Atrial Fibrillation (AF) management

This use case aims to transform the management of Atrial Fibrillation (AF), a highly prevalent chronic condition associated with increased risk of complications and hospitalisation, by moving from a reactive approach to a proactive, continuous, and patient-centred model of care.

The goal is to anticipate risks earlier, overcome current gaps in follow-up between clinical visits, extend care beyond the hospital setting, and provide patients with personalised support throughout their journey.

The vision is to build a more responsive and coordinated pathway that strengthens prevention, improves continuity of care across settings, and supports long-term cardiovascular stability.

Digital Health

Patient Empowerment

Health Innovation

Partners involved:

Innovative

From Reactive to Proactive AF Care

To achieve this shift, the use case will combine wearables, portable devices, and a secure digital platform capable of integrating physiological data, self-reported information, and follow-up assessments. This connected ecosystem will enable more continuous and comprehensive evaluation of a patient’s condition, overcoming current limitations related to fragmented data and limited visibility between clinical visits. This will help care teams identify early signs of deterioration, including intermittent or asymptomatic events, act sooner, and personalise follow-up strategies more effectively.

Patient empowerment plays a key role, particularly in a context where adherence and engagement are often limited in traditional care models. Structured educational resources and ongoing guidance encourage individuals to participate actively in their care, better understand their condition, and adopt healthier long-term habits. This contributes to stronger adherence, greater confidence, and a more engaged relationship between patients and clinicians.

Large-Scale Screening, Better Coordination, Better Outcomes

By implementing large-scale screening supported by these remote digital tools, the use case addresses current gaps in AF diagnosis, the limited detection of intermittent or asymptomatic events, and the lack of continuous follow-up in high-risk patients.

The continuous flow of data will improve visibility of patient status, reduce fragmentation across systems, and support smoother coordination between healthcare professionals. This will enable more timely and informed decision-making, helping reduce unnecessary in-person visits and clinical burden, while ensuring that patients receive the right level of care at the right time.

Improved patient satisfaction

driven by more accessible, personalised and continuous follow-up.

Earlier detection of AF events and decompensation episodes

supported by ongoing data collection through wearables and remote tools, enabling more timely clinical decisions.

Reduction in AF recurrence post-ablation

and improved long-term disease control thanks to closer observation of patient status and earlier intervention when changes are detected.

Higher adherence

to monitoring and follow-up recommendations, addressing current limitations in patient engagement.

Enhanced patient empowerment

fostered through structured education and sustained support, contributing to better self-management and overall quality of life.

Improved efficiency of care delivery

through reduced hospital visits, optimised resource use, and more proactive management of high-risk patients.